PAN-004

N/A

Report date: 2024/07/24 14:29:35

Base Information

Drug NamePAN-004
Drug Alias NamePAN-004
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionAngiopoietin-1 modulators
TargetsAngiopoietin-1
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPantherna Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesWacker Biotech GmbHPantherna Therapeutics GmbH
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A